Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (48) 48
breast cancer (47) 47
life sciences & biomedicine (46) 46
humans (42) 42
oncology (42) 42
female (40) 40
middle aged (33) 33
adult (28) 28
aged (26) 26
breast neoplasms - drug therapy (20) 20
breast neoplasms - pathology (19) 19
metastasis (17) 17
tumors (16) 16
cancer (15) 15
breast neoplasms - genetics (13) 13
medicine & public health (13) 13
treatment outcome (13) 13
care and treatment (12) 12
analysis (11) 11
biological and medical sciences (11) 11
medical sciences (11) 11
risk factors (11) 11
case-control studies (10) 10
clinical trials (10) 10
surgery (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
chemotherapy (9) 9
disease-free survival (9) 9
epidermal growth factor (9) 9
patients (9) 9
receptor, erbb-2 - metabolism (9) 9
trastuzumab (9) 9
drug therapy (8) 8
gynecology. andrology. obstetrics (8) 8
mammary gland diseases (8) 8
prognosis (8) 8
research (8) 8
surgical oncology (8) 8
antineoplastic agents - therapeutic use (7) 7
breast neoplasms - metabolism (7) 7
breast neoplasms - surgery (7) 7
cancer patients (7) 7
cancer therapies (7) 7
health aspects (7) 7
neoplasm staging (7) 7
antimitotic agents (6) 6
antineoplastic agents (6) 6
breast neoplasms - mortality (6) 6
cancer research (6) 6
japan - epidemiology (6) 6
metastases (6) 6
receptors, estrogen - metabolism (6) 6
adolescent (5) 5
epidemiology (5) 5
erbb-2 protein (5) 5
genetic aspects (5) 5
japan (5) 5
metastatic breast cancer (5) 5
neoplasm metastasis (5) 5
neutropenia (5) 5
odds ratio (5) 5
oncology, experimental (5) 5
patient outcomes (5) 5
radiation therapy (5) 5
retrospective studies (5) 5
risk (5) 5
survival (5) 5
survival analysis (5) 5
taxoids - administration & dosage (5) 5
abridged index medicus (4) 4
adjuvant treatment (4) 4
aged, 80 and over (4) 4
antibodies, monoclonal, humanized (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
asian continental ancestry group (4) 4
breast neoplasms - chemistry (4) 4
breast neoplasms - epidemiology (4) 4
chemotherapy, adjuvant (4) 4
combined modality therapy (4) 4
development and progression (4) 4
docetaxel (4) 4
drug administration schedule (4) 4
follow-up studies (4) 4
genetic predisposition to disease (4) 4
genomics (4) 4
her2 (4) 4
kaplan-meier estimate (4) 4
kinases (4) 4
medicin och hälsovetenskap (4) 4
menopause (4) 4
neoadjuvant therapy (4) 4
original (4) 4
original article (4) 4
polymorphism, single nucleotide (4) 4
receptor, erbb-2 - analysis (4) 4
receptors, progesterone - metabolism (4) 4
studies (4) 4
toxicity (4) 4
womens health (4) 4
animals (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
by Cristofanilli, Massimo, Prof and Turner, Nicholas C, MD and Bondarenko, Igor, Prof and Ro, Jungsil, MD and Im, Seock-Ah, MD and Masuda, Norikazu, MD and Colleoni, Marco, MD and DeMichele, Angela, MD and Loi, Sherene, MD and Verma, Sunil, MD and Iwata, Hiroji, MD and Harbeck, Nadia, Prof and Zhang, Ke, PhD and Theall, Kathy Puyana, MD and Jiang, Yuqiu, PhD and Bartlett, Cynthia Huang, MD and Koehler, Maria, MD and Slamon, Dennis, Prof
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Estradiol - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Estradiol - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Neoplasm Recurrence, Local - pathology | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Mutation | Medical colleges | Care and treatment | Oncology, Experimental | Clinical trials | Breast cancer | Metastasis | Hormones | Research | Antineoplastic agents | Epidemiology | Antimitotic agents | Analysis | Product development | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
by Masuda, Norikazu, MD and Sagara, Yasuaki, MD and Kinoshita, Takayuki, MD and Iwata, Hiroji, MD and Nakamura, Seigo, Prof and Yanagita, Yasuhiro, MD and Nishimura, Reiki, MD and Iwase, Hirotaka, Prof and Kamigaki, Shunji, MD and Takei, Hiroyuki, MD and Noguchi, Shinzaburo, Prof
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 345 - 352
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Aromatase Inhibitors - administration & dosage | Neoplasms, Hormone-Dependent - surgery | Breast Neoplasms - surgery | Goserelin - administration & dosage | Triazoles - administration & dosage | Triazoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Premenopause | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Breast Neoplasms - pathology | Adult | Female | Neoadjuvant Therapy | Neoplasms, Hormone-Dependent - drug therapy | Neoplasm Staging | Nitriles - adverse effects | Antimitotic agents | Menopause | Clinical trials | Product development | Breast cancer | Postmenopausal women | Tamoxifen | Antineoplastic agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
by André, Fabrice and Ciruelos, Eva and Rubovszky, Gabor and Campone, Mario and Loibl, Sibylle and Rugo, Hope S and Iwata, Hiroji and Conte, Pierfranco and Mayer, Ingrid A and Kaufman, Bella and Yamashita, Toshinari and Lu, Yen-Shen and Inoue, Kenichi and Takahashi, Masato and Pápai, Zsuzsanna and Longin, Anne-Sophie and Mills, David and Wilke, Celine and Hirawat, Samit and Juric, Dejan and SOLAR-1 Study Grp and SOLAR-1 Study Group and the SOLAR-1 Study Group
The New England journal of medicine, ISSN 0028-4793, 05/2019, Volume 380, Issue 20, pp. 1929 - 1940
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug therapy | Development and progression | Breast cancer | Cyclin-dependent kinases | Diarrhea | Endocrine therapy | Metastasis | Kinases | Patients | Cancer therapies | Survival | ErbB-2 protein | Fulvestrant | Hyperglycemia | Chemotherapy | Epidermal growth factor | Antitumor activity | Diabetes | Mutation | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Current approach and future perspective for ductal carcinoma in situ of the breast
by Kanbayashi, Chizuko and Iwata, Hiroji
Japanese journal of clinical oncology, ISSN 0368-2811, 08/2017, Volume 47, Issue 8, pp. 671 - 677
Clinical trial | Ductal carcinoma in situ | Breast cancer | Low grade DCIS | Overtreatment | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - therapy | Breast Neoplasms - surgery | Carcinoma, Intraductal, Noninfiltrating - pathology | Carcinoma, Intraductal, Noninfiltrating - therapy | Early Detection of Cancer - methods | Breast Neoplasms - pathology | Humans | Female | Carcinoma, Intraductal, Noninfiltrating - surgery | Mammography - methods | Index Medicus | ductal carcinoma in situ | low grade DCIS | clinical trial | breast cancer | Review | overtreatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer
by Cortes, Javier and Cescon, David W and Rugo, Hope S and Nowecki, Zbigniew and Im, Seock-Ah and Yusof, Mastura Md and Gallardo, Carlos and Lipatov, Oleg and Barrios, Carlos Henrique and Holgado, Esther and Iwata, Hiroji and Masuda, Norikazu and Torregroza Otero, Marco and Gokmen, Erhan and Loi, Sherene and Guo, Zifang and Zhao, Jing and Aktan, Gursel and Karantza, Vassiliki and Schmid, Peter
Journal of clinical oncology, ISSN 0732-183X, 05/2020, Volume 38, Issue 15_suppl, pp. 1000 - 1000
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study
by Watanabe, Toru and Kuranami, Masaru and Inoue, Kenichi and Masuda, Norikazu and Aogi, Kenjiro and Ohno, Shinji and Iwata, Hiroji and Mukai, Hirofumi and Uemura, Yukari and Ohashi, Yasuo
Cancer, ISSN 0008-543X, 03/2017, Volume 123, Issue 5, pp. 759 - 768
paclitaxel | adjuvant therapy | doxorubicin and cyclophosphamide (AC)‐taxane | docetaxel | randomized phase 3 | doxorubicin and cyclophosphamide (AC)-taxane | Anthracyclines - adverse effects | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymph Nodes - pathology | Humans | Middle Aged | Cyclophosphamide - adverse effects | Anthracyclines - administration & dosage | Adult | Female | Paclitaxel - administration & dosage | Taxoids - adverse effects | Japan | Docetaxel | Paclitaxel - adverse effects | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Breast Neoplasms - pathology | Adolescent | Bridged-Ring Compounds - adverse effects | Aged | Bridged-Ring Compounds - administration & dosage | Anthracyclines | Usage | Cyclophosphamide | Paclitaxel | Clinical trials | Dosage and administration | Breast cancer | Drug therapy | Comparative analysis | Edema | Lymphatic system | Nausea | Taxane | Survival | Patients | Doxorubicin | Lymph nodes | Incidence | Confidence intervals | Randomization | Motivation | Anthracycline | Vomiting | Biopsy | Surgery | Factorial design | Cancer | Neutropenia | Lymph | Index Medicus | Abridged Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Dietary patterns and the risk of breast cancer in Japanese women
by Hirose, Kaoru and Matsuo, Keitaro and Iwata, Hiroji and Tajima, Kazuo
Cancer science, ISSN 1347-9032, 09/2007, Volume 98, Issue 9, pp. 1431 - 1438
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Japan - epidemiology | Dietary Fats - adverse effects | Soybeans | Vegetables | Fruit | Diet - adverse effects | Humans | Middle Aged | Risk Factors | Alcohol Drinking | Case-Control Studies | Breast Neoplasms - prevention & control | Breast Neoplasms - psychology | Dietary Fats - administration & dosage | Adult | Diet - psychology | Female | Surveys and Questionnaires | Aged | Fish Products | Breast Neoplasms - epidemiology | Smoking | Women | Breast cancer | Health aspects | Food habits | Risk factors | Factor analysis | Family medical history | Epidemiology | Variables | Body mass index | Diet | Womens health | Alcoholic beverages | Health risk assessment | Meals | Age | Food | Rice | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
by Schmid, Peter and Rugo, Hope S and Adams, Sylvia and Schneeweiss, Andreas and Barrios, Carlos H and Iwata, Hiroji and Diéras, Véronique and Henschel, Volkmar and Molinero, Luciana and Chui, Stephen Y and Maiya, Vidya and Husain, Amreen and Winer, Eric P and Loi, Sherene and Emens, Leisha A and IMpassion130 Investigators
The lancet oncology, ISSN 1470-2045, 01/2020, Volume 21, Issue 1, pp. 44 - 59
Life Sciences & Biomedicine | Oncology | Science & Technology | Receptors, Estrogen - metabolism | Prognosis | Double-Blind Method | Follow-Up Studies | Neoplasm Invasiveness | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Albumins - administration & dosage | Survival Rate | Triple Negative Breast Neoplasms - drug therapy | Receptors, Progesterone - metabolism | Young Adult | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Triple Negative Breast Neoplasms - metabolism | Adolescent | Triple Negative Breast Neoplasms - pathology | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Paclitaxel - administration & dosage | Clinical trials | Care and treatment | Breast cancer | Metastasis | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes
by Terada, Mitsuo and Adachi, Yayoi and Sawaki, Masataka and Hattori, Masaya and Yoshimura, Akiyo and Naomi, Gondo and Kotani, Haruru and Iwase, Madoka and Kataoka, Ayumi and Onishi, Sakura and Sugino, Kayoko and Mori, Makiko and Horisawa, Nanae and Sasaki, Eiichi and Yatabe, Yasushi and Iwata, Hiroji
Breast cancer research and treatment, ISSN 0167-6806, 11/2018, Volume 172, Issue 1, pp. 1 - 7
Origin | Oncology | Breast inclusion | Occult breast cancer | Medicine & Public Health | Ectopic breast | Life Sciences & Biomedicine | Science & Technology | Axilla - pathology | Lymph Nodes - pathology | Breast Neoplasms - pathology | Humans | Breast Neoplasms - etiology | Female | Lymphatic Metastasis | Choristoma - pathology | Breast - pathology | Neoplasms, Unknown Primary - etiology | Neoplasms, Unknown Primary - pathology | Breast cancer | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence
by Sawaki, Masataka and Kodaira, Takeshi and Iwata, Hiroji
Annals of surgical oncology, ISSN 1068-9265, 12/2019, Volume 26, Issue Suppl 3, pp. S660 - S661
Oncology | Life Sciences & Biomedicine | Surgery | Science & Technology | Relapse | Breast cancer | Radiotherapy | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
by Tamura, Kenji and Tsurutani, Junji and Takahashi, Shunji and Iwata, Hiroji and Krop, Ian E and Redfern, Charles and Sagara, Yasuaki and Doi, Toshihiko and Park, Haeseong and Murthy, Rashmi K and Redman, Rebecca A and Jikoh, Takahiro and Lee, Caleb and Sugihara, Masahiro and Shahidi, Javad and Yver, Antoine and Modi, Shanu
The lancet oncology, ISSN 1470-2045, 06/2019, Volume 20, Issue 6, pp. 816 - 826
Life Sciences & Biomedicine | Oncology | Science & Technology | Care and treatment | Breast cancer | Research | Analysis | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights